Rankings
▼
Calendar
SLNO FY 2024 Earnings — Soleno Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
SLNO
Soleno Therapeutics, Inc.
$2B
FY 2024 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$188M
Net Income
-$176M
EPS (Diluted)
$-4.38
Cash Flow
Operating Cash Flow
-$69M
Free Cash Flow
-$69M
Stock-Based Comp.
$100M
Balance Sheet
Total Assets
$331M
Total Liabilities
$86M
Stockholders' Equity
$245M
Cash & Equivalents
$88M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
$0
—
Operating Income
-$188M
-$41M
-353.5%
Net Income
-$176M
-$39M
-351.0%
← Q4 2023
All Quarters
Q1 2024 →